Фармацевтическая сеть Hartig Drug расширила ассортимент продукцией Nefense

Dubuque, Iowa–(Newsfile Corp. – September 2, 2026) – Hartig Drug Company has expanded its product lineup by adding Nefense® nasal care products at select locations in Iowa, Illinois, and Wisconsin, offering customers new drug-free options for daily nasal hygiene. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: - Hartig Drug Company adds Nefense nasal care products at select stores in Iowa, Illinois, and Wisconsin, making them available now to customers seeking drug-free options for daily nasal hygiene. - The Nefense lineup features hypochlorous acid nasal sprays for adults, children, and infants, plus a xylitol spray, providing non-medicated alternatives to decongestants across age groups. - Published randomized clinical research evaluates low-concentration hypochlorous acid nasal irrigation for chronic sinonasal symptoms and allergic rhinitis, although these studies do not test Nefense-branded products. Click image above to view full announcement. About Hartig Drug Company Founded in Dubuque, Iowa, in 1904, Hartig Drug Company is a family-owned pharmacy and retail company serving communities throughout Iowa, Illinois and Wisconsin. Hartig Drug provides community pharmacy services along with health, wellness and everyday consumer products, with a continued focus on personalized service and strong local community relationships. About Nefense Nefense, Natural Wellness & Defense, is a Dubuque, Iowa-based nasal wellness company focused on daily nasal hygiene, airway care and better breathing. Developed under the direction of Richard Downs, DDS, the Nefense portfolio includes HypoNasal, HypoNasal Junior, HypoBaby and XyloClean, with hypochlorous acid and xylitol-based formulations designed for routine nasal care. Learn more at nefense.com Contacts: Dan Simon (563) 588-8700 [email protected] Source: Newsworthy.ai To view the source version of this press release, please visit https://www.newsfilecorp.com/release/312570